Leukocyte Disorders Active Not Recruiting Phase 2 / 3 Trials for Benralizumab (DB12023)

Also known as: Leukocyte Disorder

IndicationStatusPhase
DBCOND0054746 (Leukocyte Disorders)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02130882Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeTreatment